Brett Guthrie
Representative for Kentucky · Republican · United States
“(d) Study on Long-Term Symptoms or Conditions Related to Traumatic Brain Injury.-- (1) In general.--The Secretary, in consultation with stakeholders and the heads of other relevant Federal departments and agencies, as appropriate, shall conduct, either directly or through a contract with a nonprofit private entity, a study to-- (A) examin…”
“(d) Study on Long-Term Symptoms or Conditions Related to Traumatic Brain Injury.-- (1) In general.--The Secretary, in consultation with stakeholders and the heads of other relevant Federal departments and agencies, as appropriate, shall conduct, either directly or through a contract with a nonprofit private entity, a study to-- (A) examin…”
“300n-5(a))-- (A) by striking ``2011, and'' and inserting ``2011,''; and (B) by inserting ``, and $235,500,000 for each of fiscal years 2026 through 2030'' before the period at the end.”
“300n-5(a))-- (A) by striking ``2011, and'' and inserting ``2011,''; and (B) by inserting ``, and $235,500,000 for each of fiscal years 2026 through 2030'' before the period at the end.”
“360aa note) is amended-- (1) in the section heading, by striking ``als and other rare neurodegenerative disease action plan'' and inserting ``fda rare neurodegenerative disease action plan''; and (2) by adding at the end the following: ``(c) FDA Rare Neurodegenerative Disease Action Plan.-- ``(1) In general.--Not later than 18 months afte…”
“360aa note) is amended-- (1) in the section heading, by striking ``als and other rare neurodegenerative disease action plan'' and inserting ``fda rare neurodegenerative disease action plan''; and (2) by adding at the end the following: ``(c) FDA Rare Neurodegenerative Disease Action Plan.-- ``(1) In general.--Not later than 18 months afte…”
The complete record
Every one of 330 lines we hold for Brett Guthrie, in date order, each linked to its source. Free to read, in full, without an account. Page 4 of 7.
“This Act may be cited as the ``NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone Act'' or the ``NIH IMPROVE Act''. SEC. 2. IMPROVE INITIATIVE. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following: ``SEC. 409K. IMPROVE INITIATIVE. ``(a) In General.--The Director of NIH shall continue to carry out a program to improve maternal health outcomes, to be known as the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone Initiative or the `IMPROVE Initiative' (referred to in this section as the `Initiative').”
“Congressional Record, Volume 172 Issue 118 (Monday, July 20, 2026) [Congressional Record Volume 172, Number 118 (Monday, July 20, 2026)] [House] [Pages H4651-H4652] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] NIH IMPLEMENTING A MATERNAL HEALTH AND PREGNANCY OUTCOMES VISION FOR EVERYONE ACT Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 6238) to establish the IMPROVE Initiative within the National Institutes of Health, as amended. The Clerk read the title of the bill. The text of the bill is as follows: H.R. 6238 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE.”
“The question was taken; and (two-thirds being in the affirmative) the rules were suspended and the bill was passed. A motion to reconsider was laid on the table. ____________________”
“As President and CEO of the Global Down Syndrome Foundation, Michelle has been a titan of advocacy in the Down Syndrome world. As the mother of a child with Down Syndrome, she has harnessed her love for the folks in this community and channeled it into action--raising millions of dollars for research and serving as a voice for those with Down Syndrome. It is safe to say that we would not be here voting on this bill if not for her tireless work and effort. I want to personally thank Michelle for her leadership and once again reiterate my support for this bill. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Kentucky (Mr. Guthrie) that the House suspend the rules and pass the bill, H.R. 3491.”
“I was incredibly proud to support this bill as it made it's way through the legislative process in the Energy and Commerce Committee, and I am looking forward to it passing with bipartisan support on the House floor. This legislation provides statutory authority to a project that the NIH has already been carrying out for nearly a decade to investigate the co-occuring conditions that impact Americans with Down Syndrome and their quality-of-life needs. For far too long, federal investment into Down Syndrome has paced behind need. Individuals with Down Syndrome are among our most precious vulnerable citizens--they deserve this nation's support. I also want to recognize the efforts of a fellow Coloradan who was instrumental in advancing this bill: Michelle Sie Whitten.”
“In particular, I would like to highlight the role of the Quincy Jones Exceptional Advocacy Award and its founder, Michelle Sie Whitten, for their tireless advocacy to make this happen today. I again thank our co-leads, Representatives DeGette and Hudson, for their outstanding leadership. I look forward to supporting this measure on the House floor. Ms. DeGETTE. Mr. Speaker, I yield back the balance of my time. Mr. GUTHRIE. Mr. Speaker, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. Mr. EVANS of Colorado. Speaker, I rise today in strong support of the Deondra Dixon INCLUDE Project Act of 2025.”
“The DeOndra Dixon INCLUDE Project Act will help ensure the NIH INCLUDE Project continues advancing research that improves health outcomes, expands scientific understanding, and enhances quality of life for individuals with Down syndrome and their families. This legislation builds upon one of our Nation's most successful investments in Down syndrome research. Already, these investments have led to major breakthroughs in how Down syndrome interacts with other health conditions that have a high incidence in the community, such as immune system disorders, cancer, Alzheimer's, and more. [[Page H4651]] Every one of these breakthroughs carries the hope for a brighter tomorrow for individuals living with Down syndrome. I would also like to recognize that this progress doesn't happen without sustained advocacy.”
“I urge my colleagues to join Representative Hudson and me to support the bill, and I reserve the balance of my time. Mr. GUTHRIE. Mr. Speaker, I have no further speakers. I reserve the balance of my time. Ms. DeGETTE. Mr. Speaker, I yield 2 minutes to the distinguished gentleman from New York (Mr. Tonko), another great advocate for this bill. Mr. TONKO. Mr. Speaker, I thank my colleague from Colorado for yielding. I rise in strong support of the DeOndra Dixon INCLUDE Project Act and applaud my colleagues, Representative Diana DeGette and Richard Hudson, for championing this critical piece of legislation.”
“I know it is a labor of love and deeply personal for her family and every family that has been touched by Down syndrome. It has been an honor to also work with my constituent, Michelle Sie Whitten, the president of the Quincy Jones Exceptional Advocacy Award, a driving force for this bill, and a fierce advocate for her daughter and everyone with Down syndrome. It has also been an honor to work with my friend and colleague Representative Hudson, whose dedication to the Down syndrome community has been essential to push this bill closer to the finish line. I simply could not have had a better partner on this issue. The INCLUDE Project Act will ensure that critical Down syndrome research continues to advance. This year, it must finally be enacted into law.”
“I am so proud that much of this work is happening right in my home district of Denver, Colorado. The Crnic Institute for Down syndrome on the Anschutz Medical Campus leads more than 200 scientists at the largest Down syndrome research facility in the world. They see incredible breakthroughs every day. This type of innovation puts science first and benefits not only individuals living with Down syndrome and their families but every single one of us because we are learning more and more about disease biology and just why some conditions work differently in people with Down syndrome. It is why the bill passed the House last Congress with unanimous support. I am so happy that I was able to work for many years with my friend, the former chair of the Energy and Commerce Committee, Cathy McMorris Rodgers, on this bill in the last Congress.”
“I encourage my colleagues to support this bill, and I reserve the balance of my time. {time} 1600 Ms. DeGETTE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, my bill with Representative Hudson, the DeOndra Dixon INCLUDE Project Act, codifies the renaissance in Down syndrome research at NIH that was kicked off when the INCLUDE Project began in 2018. This bill sustains and encourages this critical research. After being left behind by NIH for nearly 20 years, the Down syndrome community is finally seeing research advancements that will extend and improve their lives. What we learn from this research will not only help us better understand Down syndrome but also heart disease, Alzheimer's, cancer, and many co-occurring conditions.”
“3491. The SPEAKER pro tempore. Is there objection to the request of the gentleman from Kentucky? There was no objection. Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in strong support of H.R. 3491, led by my colleagues Representatives DeGette and Hudson. This bill would authorize the INCLUDE Project at the National Institutes of Health, which advances research into Down syndrome to improve the health and quality of life of individuals with Down syndrome and their families. This project investigates conditions that affect people with Down syndrome, as well as the general public, with a hope of improving our understanding of the condition and advancing the quality-of-life outcomes for individuals with Down syndrome and patients facing similar medical issues.”
“``(2) Contents.--Each report under paragraph (1) shall include-- ``(A) identification of the institute or center involved; ``(B) a statement of whether the research is or was being carried out directly by such institute or center or by multiple institutes and centers; and ``(C) identification of any resulting real-world evidence that is or may be used for clinical research and medical care for patients with Down syndrome.''. The SPEAKER pro tempore. Pursuant to the rule, the gentleman from Kentucky (Mr. Guthrie) and the gentlewoman from Colorado (Ms. DeGette) each will control 20 minutes. The Chair recognizes the gentleman from Kentucky. General Leave Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and include extraneous material on H.R.”
“``(e) Biennial Reports to Congress.-- ``(1) In general.--The Director of NIH shall submit, on a biennial basis, to the Committee on Energy and Commerce and the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies of the Committee on Appropriations of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies of the Committee on Appropriations of the Senate, a report that catalogs the research conducted or supported under this section.”
“``(d) Consultation With Stakeholders.--In carrying out activities under this section, the Director of NIH shall, as appropriate and to the maximum extent feasible, consult with relevant stakeholders, including patient advocates, to ensure that such activities take into consideration the needs of individuals with Down syndrome.”
“``(c) Coordination; Prioritizing Nonduplicative Research.-- The Director of NIH shall ensure that-- ``(1) the programs and activities of the institutes and centers of the National Institutes of Health relating to Down syndrome and co-occurring conditions are coordinated, including through the Office of the Director of NIH and priority-setting reviews conducted pursuant to section 402(b)(3); and ``(2) such institutes and centers, prioritize, as appropriate, Down syndrome research that does not duplicate existing research activities of the National Institutes of Health.”
“``(b) Program Elements.--The program under subsection (a) shall include-- ``(1) high-risk, high-reward research on the effects of trisomy 21 on human development and health; ``(2) promoting research for participants with Down syndrome across the lifespan, including cohort studies to facilitate improved understanding of Down syndrome and co- occurring conditions and development of new interventions; ``(3) expanding the number of clinical trials that are inclusive of, or expressly for, participants with Down syndrome, including novel biomedical and pharmacological interventions and other therapies designed to promote or enhance activities of daily living; ``(4) research on the biological mechanisms in individuals with Down syndrome pertaining to structural, functional, and behavioral anomalies and dysfunction as well as stunted growth; ``(5) supporting research to improve diagnosis and treatment of conditions co-occurring with Down syndrome, including the identification of biomarkers related to risk factors, diagnosis, and clinical research and therapeutics; ``(6) research on the causes of increased prevalence, and concurrent treatment, of co-occurring conditions, such as Alzheimer's disease and related dementias and autoimmunity, in individuals with Down syndrome; and ``(7) research, training, and investigation on improving the quality of life of individuals with Down syndrome and their families.”
“This Act may be cited as the ``DeOndra Dixon INCLUDE Project Act of 2025''. SEC. 2. DEONDRA DIXON INCLUDE PROJECT. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following: ``SEC. 409K. DOWN SYNDROME RESEARCH. ``(a) In General.--The Director of NIH shall carry out a program of research, training, and investigation related to Down syndrome to be known as the `INvestigation of Co- occurring conditions across the Lifespan to Understand Down syndromE Project' or the `INCLUDE Project'.”
“Congressional Record, Volume 172 Issue 118 (Monday, July 20, 2026) [Congressional Record Volume 172, Number 118 (Monday, July 20, 2026)] [House] [Pages H4649-H4651] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] DEONDRA DIXON INCLUDE PROJECT ACT OF 2025 Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3491) to amend the Public Health Service Act to authorize the Secretary of Health and Human Services to carry out a program of research, training, and investigation related to Down syndrome, and for other purposes. The Clerk read the title of the bill. The text of the bill is as follows: H.R. 3491 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, [[Page H4650]] SECTION 1. SHORT TITLE.”
“The question was taken. The SPEAKER pro tempore. In the opinion of the Chair, two-thirds being in the affirmative, the ayes have it. Mr. GUTHRIE. Mr. Speaker, on that I demand the yeas and nays. The yeas and nays were ordered. The SPEAKER pro tempore. Pursuant to clause 8 of rule XX, further proceedings on this motion will be postponed. ____________________”
“It can be the difference between life and death, especially in combating breast cancer, especially for those with inherited mutations and women at higher risk, like Black women, for whom a deadlier form of breast cancer known as triple negative is more likely. Mr. Speaker, I urge my colleagues to support this legislation, the Senate to quickly pass it, and the President to make it law. Breast cancer diagnoses are on the rise in younger women, and we must meet this moment. Ms. DeGETTE. Mr. Speaker, I yield back the balance of my time. Mr. GUTHRIE. Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Kentucky (Mr. Guthrie) that the House suspend the rules and pass the bill, H.R. 4541, as amended.”
“Unfortunately, too many young women and high-risk women are dismissed by healthcare providers thinking, ``Oh, what you have is just a cyst,'' or, ``Young women don't get breast cancer.'' The bottom line is reauthorizing the EARLY Act saves women's lives, and I am proud to team up with Representatives Miller-Meeks, Castor, Fitzpatrick, Dingell, and Harshbarger, and Senators Klobuchar and Crapo, to make sure those resources are out there for all of us. The SPEAKER pro tempore. The time of the gentlewoman has expired. Ms. DeGETTE. Mr. Speaker, I yield an additional 30 seconds to the gentlewoman from Florida. Ms. WASSERMAN SCHULTZ. Mr. Speaker, early detection is our most powerful tool to beat cancer.”
“Since it first became law, breast cancer cases have steadily risen by 1.4 percent annually for women under 50, twice the rate of older women, and by as much as 3.5 percent in women between 20 and 29. The law created three CDC programs that helped young and high-risk women focus on breast cancer risks and address the reality of rising breast cancer rates in young women. The Bring Your Brave campaign amplifies stories to raise awareness in young women 18 to 44 about unique risks, signs, and symptoms. The Young Breast Cancer Survivors Program funds grants for nonprofits that provide support services and resources to boost patient survival and their quality of life. It also ensures healthcare providers know the unique challenges that breast cancer poses to young and high-risk women.”
“Almost 18 years ago, when I was just 41 years old, I heard those four harrowing words: ``You have breast cancer.'' I can tell you, I remember feeling like I was being crushed by an anvil. Like many Ashkenazi Jewish women, I found out I carry the BRCA2 gene mutation, making me far more likely to get breast cancer and ovarian cancer during my lifetime, and far more likely for recurrence. After 15 months and many surgeries and tons of support from family and close friends, I was cancer-free. Finding it early saved my life, and now we have generational awareness of this genetic risk in my family. Millions of young women need these same tools, so once I was cancer- free, I passed the original EARLY Act, which became law in 2010.”
“I thank him for continuing the fight against cancer with us. Mr. Speaker, I am proud to rise in strong support of my bipartisan bill, the Breast Health Education and Awareness Requires Learning Young Act, or the EARLY Act Reauthorization of 2025. First, I thank Chairman Guthrie and Ranking Member Pallone for their strong support of this legislation, because one in eight American women, as you have heard, will get breast cancer, and 42,000 are expected to lose their life from it this year. The earlier it is caught, the better our chances are to survive and beat it. When breast cancer is caught in its earliest stage, survival rates shoot up to 99 percent. Trust me. I know catching it early saved my life.”
“I know he talked about his mom and his sister, but as we all know, those of us who have been here a little bit of time, his brother was our colleague and had cancer as well. We miss him. May God bless his family. Mr. Speaker, I reserve the balance of my time. Ms. DeGETTE. Mr. Speaker, I yield 3 minutes to the gentlewoman from Florida (Ms. Wasserman Schultz), a fierce advocate and long-term fighter for early breast cancer detection. Ms. WASSERMAN SCHULTZ. Mr. Speaker, I thank the gentlewoman for yielding. To my colleague from Pennsylvania (Mr. Fitzpatrick), I was proud to be elected in the same class as his late brother, Mike. He was a good and decent man, someone who always reached across the aisle. I was really fortunate to be able to serve with him and with the current Congressman Fitzpatrick.”
“This legislation reauthorizes the National Breast and Cervical Cancer Early Detection Program, expanding services to ensure more Americans, especially those who are low income or underinsured, can receive early lifesaving care. Mr. Speaker, passing H.R. 4541 is a critical step in ensuring that more Americans have access to early detection services and education. We can prevent needless suffering and needless loss of life. I thank my co-chair of the House Cancer Caucus, Representative Debbie Wasserman Schultz, for leading the EARLY Act, and Representative Morelle for his work in leading the SCREENS for Cancer Act. Mr. Speaker, I urge all my colleagues to support this bipartisan legislation. Mr. GUTHRIE. Mr. Speaker, I commend my colleague.”
“Speaker, to reauthorize the Breast Cancer Education and Awareness Requires Learning Young, or EARLY Act, a proven lifesaving initiative that promotes early detection and education for young and high-risk women. Breast cancer remains the most common cancer among women, with over 300,000 new cases and 42,000 projected deaths in 2025. I have seen the power of early detection up close, Mr. Speaker. Both my mom and my sister are breast cancer survivors. This is a very, very personal issue. It shows how early detection is the most effective tool there is to improve outcomes. Also included in this legislation is the SCREENS for Cancer Act, which I am proud to co-lead.”
“Despite these realities, younger women between the ages of 25 and 40 continue to face disproportionately high rates of aggressive breast cancers. The EARLY Act has helped drive national progress in breast cancer awareness, education, and prevention. H.R. 4541 reauthorizes these critical efforts. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time. {time} 1550 Mr. GUTHRIE. Mr. Speaker, I yield 4 minutes to the gentleman from Pennsylvania (Mr. Fitzpatrick), my good friend and a member of the Ways and Means Committee. Mr. FITZPATRICK. Mr. Speaker, I thank the chairman for his work in this regard. I am proud to co-lead this critical legislation, Mr.”
“Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in strong support of H.R. 4541, the EARLY Act Reauthorization of 2025. Breast cancer remains the most common cancer among women, with 321,000 new cases and 42,000 projected deaths just this year alone. While breast cancer is often thought of as affecting older women, younger women are often diagnosed too late, where treatment options are more limited and, frankly, outcomes are worse. Approximately 16 percent of all new breast cancer cases occur in women under the age of 50. The importance of early detection simply cannot be overstated. [[Page H4649]] Women diagnosed at an early stage have survival rates exceeding 99 percent. However, that number can fall to 30 percent when breast cancer is detected at later stages.”
“This bill reauthorizes funding for the Young Women's Breast Health Education and Awareness Requires Learning Young Act, which supports critical education, outreach, and provider training efforts through HHS, acting through the CDC to close the gaps between screening and detection of breast cancer in women under the age of 45 and those at high risk. Breast cancer is the second most common cancer and second leading cause of cancer death among American women, claiming the lives of roughly 42,000 women annually. The EARLY Act has played a significant role in increasing breast cancer awareness and prevention efforts, and we must vote today to ensure future generations of women continue to benefit from these efforts. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time. Ms. DeGETTE. Mr.”
“The SPEAKER pro tempore. Pursuant to the rule, the gentleman from Kentucky (Mr. Guthrie) and the gentlewoman from Colorado (Ms. DeGette) each will control 20 minutes. The Chair recognizes the gentleman from Kentucky. General Leave Mr. GUTHRIE. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and to include extraneous material on H.R. 4541. The SPEAKER pro tempore. Is there objection to the request of the gentleman from Kentucky? There was no objection. Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 4541, led by my colleagues Representatives Wasserman Schultz and Miller-Meeks.”
“300n-5(a))-- (A) by striking ``2011, and'' and inserting ``2011,''; and (B) by inserting ``, and $235,500,000 for each of fiscal years 2026 through 2030'' before the period at the end. (b) GAO Study.--Not later than September 30, 2027, the Comptroller General of the United States shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the work of the National Breast and Cervical Cancer Early Detection Program, including-- (1) an estimate of the number of individuals eligible for services provided under such program; (2) a summary of trends in the number of individuals served through such program; and (3) an assessment of any factors that may be driving the trends identified under paragraph (2), including any barriers to accessing breast and cervical cancer screenings provided by such program.”
“300n-4(b))-- (A) by striking ``1 year after the date of the enactment of the National Breast and Cervical Cancer Early Detection Program Reauthorization of 2007, and annually thereafter,'' and inserting ``2 years after the date of enactment of the SCREENS for Cancer Act of 2025, and every 5 years thereafter,''; (B) by striking ``Labor and Human Resources'' and inserting ``Health, Education, Labor, and Pensions''; and (C) by striking ``preceding fiscal year'' and inserting ``preceding 2 fiscal years in the case of the first report after the date of enactment of the SCREENS for Cancer Act of 2025, and preceding 5 fiscal years for each report thereafter,''; and (4) in section 1510(a) (42 U.S.C.”
“300m)-- (A) in subsection (a)-- (i) in paragraph (1), by striking ``that, initially'' and all that follows through the semicolon and inserting ``that appropriate breast and cervical cancer screening and diagnostic services are provided consistent with relevant evidence-based recommendations; and''; (ii) by striking paragraphs (2) and (4); (iii) by redesignating paragraph (3) as paragraph (2); and (iv) in paragraph (2), as so redesignated, by striking ``; and'' and inserting a period; and (B) by striking subsection (d); (3) in section 1508(b) (42 U.S.C.”
“300k)-- (A) in subsection (a)-- (i) in paragraph (2), by striking ``the provision of appropriate follow-up services and support services such as case management'' and inserting ``that appropriate follow-up services are provided''; (ii) in paragraph (3), by striking ``programs for the detection and control'' and inserting ``programs for the prevention, detection, and control''; (iii) in paragraph (4), by striking ``the detection and control'' and inserting ``the prevention, detection, and control''; (iv) in paragraph (5)-- (I) by striking ``monitor'' and inserting ``ensure''; and (II) by striking ``; and'' and inserting a semicolon; (v) by redesignating paragraph (6) as paragraph (9); (vi) by inserting after paragraph (5) the following: ``(6) to enhance appropriate support activities to increase breast and cervical cancer screenings, such as navigation of health care services, implementation of evidence-based or evidence-informed strategies to increase breast and cervical cancer screening in health care settings, and facilitation of access to health care settings; ``(7) to reduce disparities in breast and cervical cancer incidence, morbidity, and mortality, including in populations with higher than average rates; ``(8) to improve access to breast and cervical cancer screening and diagnostic services and reduce related barriers, including factors that relate to negative health outcomes; and''; and (vii) in paragraph (9), as so redesignated, by striking ``through (5)'' and inserting ``through (8)''; and (B) by striking subsection (d); (2) in section 1503 (42 U.S.C.”
“REAUTHORIZATION OF THE YOUNG WOMEN'S BREAST HEALTH EDUCATION AND AWARENESS REQUIRES LEARNING YOUNG ACT OF 2009. Section 399NN(h) of the Public Health Service Act (42 U.S.C. 280m(h)) is amended by striking ``2026'' and inserting ``2031''. TITLE II--SCREENS FOR CANCER ACT SEC. 201. SHORT TITLE. This title may be cited as the ``Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025'' or the ``SCREENS for Cancer Act of 2025''. SEC. 202. NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM. (a) National Breast and Cervical Cancer Early Detection Program.--Title XV of the Public Health Service Act (42 U.S.C. 300k et seq.) is amended-- (1) in section 1501 (42 U.S.C.”
“Congressional Record, Volume 172 Issue 118 (Monday, July 20, 2026) [Congressional Record Volume 172, Number 118 (Monday, July 20, 2026)] [House] [Pages H4648-H4649] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] EARLY ACT REAUTHORIZATION OF 2025 Mr. GUTHRIE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 4541) to reauthorize the Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009, as amended. The Clerk read the title of the bill. The text of the bill is as follows: H.R. 4541 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, TITLE I--EARLY ACT REAUTHORIZATION SEC. 101. SHORT TITLE. This title may be cited as the ``EARLY Act Reauthorization of 2025''. SEC. 102.”
“The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Kentucky (Mr. Guthrie) that the House suspend the rules and pass the bill, H.R. 1493, as amended. The question was taken; and (two-thirds being in the affirmative) the rules were suspended and the bill, as amended, was passed. A motion to reconsider was laid on the table. ____________________”
“Speaker, this is a commonsense, bipartisan bill that benefits all Americans. It advanced out of committee without a single dissenting vote. This bill supports research. It strengthens care, and it helps ensure that Americans living with traumatic brain injuries are not left behind. Mr. Speaker, I urge my colleagues to vote ``yes,'' and I reserve the balance of my time. Mr. GUTHRIE. Mr. Speaker, I am prepared to close, and I reserve the balance of my time. Mr. PALLONE. Mr. Speaker, I encourage my colleagues to support this bill on a bipartisan basis, in part because of how important it is but in part also because it honors my friend Congressman Bill Pascrell. Mr. Speaker, I yield back the balance of my time. Mr. GUTHRIE. Mr. Speaker, in closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time.”
“Third, it reauthorizes the State Protection and Advocacy program, which safeguards the rights of Americans living with brain injury. This is a modest Federal investment with an extraordinary reach. Since 1997, 48 States, 2 territories, and the District of Columbia have used these partnership grants to build the very systems that their residents now rely on. This bill does not simply extend those programs but strengthens them. It requires the Department of Health and Human Services to conduct a study and report to Congress on traumatic brain injury, and it directs the CDC to publish information on the populations at highest risk and on the strategies to protect them so that Congress and our [[Page H4648]] public health officials can respond to the growing needs of these communities with better data and clear priorities. Mr.”
“Without reauthorization, research slows, surveillance weakens, and the support services that patients and families depend on are put in jeopardy. We cannot afford to lose momentum on an issue that touches veterans, athletes, survivors of violence, older adults, and countless other Americans in every one of our districts. Mr. Speaker, H.R. 1493 renews three proven programs. First, it reauthorizes the CDC's TBI program, which drives our national research, surveillance, and prevention efforts. Second, it reauthorizes the Administration for Community Living's State partnership grant programs, which helps States, Tribal organizations, and their partners connect survivors to rehabilitation and community-based services.”
“There is also the economic toll of treating, rehabilitating, and caring for these individuals throughout their lives. Mr. Speaker, Congress' investment gave us the tools to act on what the data revealed, from concussion guidelines to protect young athletes to targeted prevention for the older Americans who are most likely to be hospitalized. None of that existed before the Federal partnership and Representative Pascrell's leadership. All of that is at risk if we continue to allow this work to lapse. Since the program's inception in 1996, Congress has reauthorized this act on a bipartisan basis time and again. However, despite bipartisan efforts by our committee to continue reauthorizing these programs, the Federal authorization lapsed in 2024.”
“That first law authorized Federal support and programs to research TBI research and conduct surveillance, both directly and through grants to public and nonprofit organizations. Mr. Speaker, this initial Federal investment has transformed what we know now and identified what we still need to do. Because Congress chose to invest, we now know that traumatic brain injury sends more than 214,000 Americans to the hospital in a single year and that it takes roughly 69,000 lives annually, nearly 190 deaths every single day. We know that more than 5.3 million Americans are living today with a lifelong disability caused by a brain injury, and we know who is most at risk: older adults who fall, servicemembers and veterans, athletes on playing fields across the country, victims of domestic violence, and far, far too many children.”
“It also renames the national TBI surveillance program to honor the legacy of my dear friend, the late Representative Bill Pascrell, Jr., of New Jersey, who founded and led the Congressional Brain Injury Task Force for more than two decades after meeting his constituent Dennis Benigno of Clifton, New Jersey, whose son suffered a life-changing traumatic brain injury in a car crash. The Traumatic Brain Injury Act was signed into law in 1996. At that time, our understanding of these injuries was so limited that public health experts called TBI the silent epidemic, and we did not know how many Americans were affected each year, who was most at risk, or how many people were left with a permanent, life-altering disability.”
“Though we may make every effort to prevent TBI from occurring in the first place, it is critical that when a TBI occurs, we are prepared and ready to employ resources that support patients in their recovery and rehabilitation. Mr. Speaker, I encourage my colleagues to support this bill, and I reserve the balance of my time. Mr. PALLONE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 1493, my bill to reauthorize the Traumatic Brain Injury Act of 1996. This bipartisan legislation reauthorizes through fiscal year 2030 the critical Federal programs dedicated to the prevention, detection, treatment, and surveillance of traumatic brain injuries.”
“Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks on the legislation and to include extraneous material on H.R. 1493. The SPEAKER pro tempore. Is there objection to the request of the gentleman from Kentucky? There was no objection. {time} 1540 Mr. GUTHRIE. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1493, led by my colleagues Representatives Pallone and Bacon, which would reauthorize HHS programs that allocate resources for traumatic brain injury prevention, improving access to TBI rehabilitation and TBI patient advocacy systems. TBI is a significant public health burden and a major driver of death and disability. In 2021 alone, there were over 69,000 TBI-related deaths.”
“(2) Public report.--Not later than 2 years after the date of enactment of this Act, the Secretary shall-- (A) submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report detailing the findings, conclusions, and recommendations of the study described in paragraph (1); and (B) in the case that such study is conducted directly by the Secretary, make the report described in subparagraph (A) publicly available on the website of the Department of Health and Human Services. The SPEAKER pro tempore. Pursuant to the rule, the gentleman from Kentucky (Mr. Guthrie) and the gentleman from New Jersey (Mr. Pallone) each will control 20 minutes. The Chair recognizes the gentleman from Kentucky. General Leave Mr. GUTHRIE. Mr.”
“(d) Study on Long-Term Symptoms or Conditions Related to Traumatic Brain Injury.-- (1) In general.--The Secretary, in consultation with stakeholders and the heads of other relevant Federal departments and agencies, as appropriate, shall conduct, either directly or through a contract with a nonprofit private entity, a study to-- (A) examine the incidence and prevalence of long-term or chronic symptoms or conditions in individuals who have experienced a traumatic brain injury; (B) examine the evidence base of research related to the chronic effects of traumatic brain injury across the lifespan; (C) examine any correlations between traumatic brain injury and increased risk of other conditions, such as dementia and mental health conditions; (D) assess existing services available for individuals with such long-term or chronic symptoms or conditions; and (E) identify any gaps in research related to such long-term or chronic symptoms or conditions of individuals who have experienced a traumatic brain injury.”
“10284); (2) an outline of existing surveys and activities of the Centers for Disease Control and Prevention on traumatic brain injuries and any steps the agency has taken to address gaps in data collection related to such higher risk populations, which may include leveraging surveys such as the National Intimate Partner and Sexual Violence Survey to collect data on traumatic brain injuries; (3) an overview of any outreach or education efforts to reach such higher risk populations; and (4) any challenges associated with reaching such higher risk populations.”